Joule 5, 2687–2714 October 20, 2021 Cell Press
Information and Approaches for developing Country Settings
Product:BDFACSCountTM InstrumentSystemwithFACSCountTM ControlKitandBD FACSCountTM CD4ReagentKit(AbsoluteandPercentageCD4+Counts)
Number: PQDx 0133-045-00
0133-045-00 WHO
PQDx PR
June/2016, version 2.0
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov...ide population-wide access to essential medicines.
Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products.
This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
more
Recomendaciones para un enfoque de salud pública
Segunda edición 2016
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
Jeder ehrenamtliche Helfer in und um Würzburg kann sich an Standpunkt e.V. wenden und kostenlos Skripte bekommen. Schreibt dazu bitte eine Mail an info@standpunkt-ev.de
Mood disorders
Chapter E.3
2016 edition
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Trastornos externalizantes
Capítulo D.3
Edición: Matías Irarrázaval & Andres Martin
Traducción: Fernanda Prieto Tagle, Sofía Hacohen Domené
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
BMC Public Health (2019) 19:1608
https://doi.org/10.1186/s12889-019-7853-3